LINKS:
Deutsche Vereinigung Morbus Bechterew e.V. – Bundesverband, https://www.bechterew.de/startseite/
Deutsche Rheuma-Liga Bundesverband e. V., https://www.rheuma-liga.de
Deutsche Gesellschaft für Rheumatologie e.V., https://dgrh.de
QUELLEN:
S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Version: 2019. https://www.awmf.org/uploads/tx_szleitlinien/060-003l_S3_Axiale-Spondyloarthritis-Morbus-Bechterew-Fruehformen-2019-10.pdf
Leitfaden Axiale Spondyloarthritis 2019, Erstellt von der ASPAT (Austrian Spondyloarthritis task Force). https://rheumatologie.at/_cms/files/doc/2019_11_Leitfaden_axSpA_interaktiv_der_ASPAT.pdf
Feldtkeller, Ernst Prof. Dr., "Entzündliche Wirbelsäulen-Krankheiten (Spondyloarthritiden)", Deutsche Vereinigung Morbus Bechterew e.V. – Bundesverband 2012. https://www.bechterew.de/fileadmin/user_upload/SpA-Flyer_A4.pdf
Morbus Bechterew, Faltblatt Deutsche Rheuma-Liga Bundesverband e. V 2020. https://www.rheuma-liga.de/fileadmin/public/main_domain/Dokumente/Mediencenter/Publikationen/Informationen/C187_Faltblatt_Morbus_Bechterew.pdf
Morbus Bechterew Mehr als „nur“ Rückenschmerzen, Faltblatt Deutsche Rheuma-Liga Bundesverband e. V 2016. https://www.rheuma-liga.de/fileadmin/public/main_domain/Dokumente/Mediencenter/Publikationen/Informationen/C168_Flyer_MorbusBechterew.pdf
Rheuma in Zahlen: Betroffene Menschen in Deutschland. https://dgrh.de/Start/DGRh/Presse/Daten-und-Fakten/Rheuma-in-Zahlen.html
Amador-Patarroyo et al., “How Does Age at Onset Influence the Outcome of Autoimmune Diseases?”, Autoimmunity Reviews, vol. 2012, pp. 1-8, 2011.
Atlas, Deyo, “Evaluating and Managing Acute Low Back Pain in the Primary Care Setting”, JGIM, vol. 16, pp.120-131, 2001.
Baraliakos et al., “Efficiency of treatment with non-steroidal anti-inflammatory drugs according to currency recommendations in patients with radiographic and non-radiographic axial spondyloarthritis”, Rheumatology, vol. 56, pp. 95-102, 2016.
Boonen et al., “The burden of non-radiographic axial spondyloarthris”, Seminars in Arthritis and Rheumatism, vol. 44, pp. 556-562, 2015.
Diekhoff T, Eshed I, Radny F, et al "Choose wisely: imaging for diagnosis of axial spondyloarthritis", Published Online First: 28 May 2021
Haibel, H., Redeker, I., Zink, A. et al. Gesundheitsversorgung und Krankheitslast bei Personen mit axialer Spondyloarthritis in Deutschland. Z Rheumatol 78, 865–874 (2019).
Hay et al., “The Extent and Characteristics of Diagnostic Delay in axSpA: A Systematic Review”, Keele University School for Primary, Community and Social Care, vol. ii126, pp. 1-2, 2020.
First, Louie, “Targeting inflammatory pathways in axial spondyloarthritis”, Arthritis Research & Therapy, vol. 21, pp. 1-15, 2019.
Mease et al., “Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry”, Arthritis Care & Research, vol. 70, pp. 1661-1670, 2018.
Morrow, “Defining the Difference: What Makes Biologics Unique”, Biotechnology Healthcare, pp. 25-29, 2004.
National Institutes of Health, “Low Back Pain”, vol. 20, pp. 1-24, 2020.
Ortolan et al., “Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort”, Arthritis Research & Therapy, vol. 20, pp. 1-8, 2018.
Poddubnyy D: "Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis", Rheumatology, Volume 59, Issue Supplement_4, October 2020, Pages iv6–iv17
Proft F et al.,"Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa", Seminars in Arthritis and Rheumatism, Volume 50, Issue 5, October 2020, Pages 1015-1021
Redeker I et al., "Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data", Rheumatology, Volume 58, Issue 9, September 2019, Pages 1634–1638
Rubin, “Epidemiology and Risk Factors for Spine Pain”, Neurol Clin, vol. 25, pp. 353-371, 2007.
Rudwaleit et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection”, Ann Rheum Dis, vol. 68, pp. 777-783, 2009.
Rusman et al., “Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky”, Current Rheumatology Reports, vol. 20:35, pp. 1-12, 2018.
Schmidt, C.O., Günther, KP., Goronzy, J. et al., "Häufigkeiten muskuloskelettaler Symptome und Erkrankungen in der bevölkerungsbezogenen NAKO Gesundheitsstudie", Bundesgesundheitsblatt 63, 415–425 (2020)
Sieper, J., Poddubnyy, D. Pathogenese der Spondyloarthritiden. Z Rheumatol 79, 5–12 (2020).
Sieper J, Poddubnyy D, "Axial spondyloarthritis" Lancet. 2017 Jul 1;390(10089):73-84.
Sieper, Rudwaleit, “Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care”, Ann Rheum Dis, vol. 64, pp. 659-663, 2005.
Sieper et al., “The IL-23--IL-17 pathways as a therapeutic target in axial spondyloarthritis”, Nature Reviews, vol. 15, pp. 747-757, 2019.
Strand, Singh, “Patient Burden of Axial Spondyloarthritis”, J Clin Rheumatol, vol. 23, pp. 383-391, 2017.
Strand, Singh, “Evaluation and Management of the Patient With Suspected Inflammatory Spine Disease”, Mayo Clinic, vol. 92, pp. 555-564, 2017.
Torgutalp, Poddubnyy, “IL-17 inhibition in axial spondyloarthritis: current and future perspectives”, Expert Opinion on Biological Therapy, vol. 19, pp. 631-641, 2019.
Wadeley et al., “Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood”, Clinical Rheumatology, vol. 37, pp. 1045-1052, 2018.
Weisman, “Inflammatory Back Pain”, Rheum Dis Clin North Am., vol. 38, pp. 501-512, 2012.
Weisman, “The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10”, Ann Rheum Dis, vol. 72, pp. 369-373, 2013.